341 related articles for article (PubMed ID: 33549047)
1. Clinical efficacy of fecal microbiota transplantation for patients with small intestinal bacterial overgrowth: a randomized, placebo-controlled clinic study.
Xu F; Li N; Wang C; Xing H; Chen D; Wei Y
BMC Gastroenterol; 2021 Feb; 21(1):54. PubMed ID: 33549047
[TBL] [Abstract][Full Text] [Related]
2. Small Intestinal Bacterial Overgrowth: Should Screening Be Included in the Pre-fecal Microbiota Transplantation Evaluation?
Allegretti JR; Kassam Z; Chan WW
Dig Dis Sci; 2018 Jan; 63(1):193-197. PubMed ID: 29188472
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation.
Kuai XY; Yao XH; Xu LJ; Zhou YQ; Zhang LP; Liu Y; Pei SF; Zhou CL
Microb Cell Fact; 2021 May; 20(1):98. PubMed ID: 33985520
[TBL] [Abstract][Full Text] [Related]
4. Transplanting Fecal Virus-Like Particles Reduces High-Fat Diet-Induced Small Intestinal Bacterial Overgrowth in Mice.
Lin DM; Koskella B; Ritz NL; Lin D; Carroll-Portillo A; Lin HC
Front Cell Infect Microbiol; 2019; 9():348. PubMed ID: 31750259
[TBL] [Abstract][Full Text] [Related]
5. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
[TBL] [Abstract][Full Text] [Related]
6. Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study.
Li N; Chen H; Cheng Y; Xu F; Ruan G; Ying S; Tang W; Chen L; Chen M; Lv L; Ping Y; Chen D; Wei Y
Front Cell Infect Microbiol; 2021; 11():759435. PubMed ID: 34737978
[TBL] [Abstract][Full Text] [Related]
7. Serial Frozen Fecal Microbiota Transplantation in the Treatment of Chronic Intestinal Pseudo-obstruction: A Preliminary Study.
Gu L; Ding C; Tian H; Yang B; Zhang X; Hua Y; Zhu Y; Gong J; Zhu W; Li J; Li N
J Neurogastroenterol Motil; 2017 Apr; 23(2):289-297. PubMed ID: 27840368
[TBL] [Abstract][Full Text] [Related]
8. Fecal Coprococcus, hidden behind abdominal symptoms in patients with small intestinal bacterial overgrowth.
Guo H; Chen Y; Dong W; Lu S; Du Y; Duan L
J Transl Med; 2024 May; 22(1):496. PubMed ID: 38796441
[TBL] [Abstract][Full Text] [Related]
9. Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial.
Yu EW; Gao L; Stastka P; Cheney MC; Mahabamunuge J; Torres Soto M; Ford CB; Bryant JA; Henn MR; Hohmann EL
PLoS Med; 2020 Mar; 17(3):e1003051. PubMed ID: 32150549
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy analysis of fecal microbiota transplantation in the treatment of 2010 patients with intestinal disorders].
Li N; Tian HL; Chen QY; Yang B; Ma CL; Lin ZL; Zhang XY; Zhao D; Huang ZX; Jiang J; Qin HL
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):861-868. PubMed ID: 31550826
[No Abstract] [Full Text] [Related]
11. Microbiota, Microbial Metabolites, and Barrier Function in A Patient with Anorexia Nervosa after Fecal Microbiota Transplantation.
Prochazkova P; Roubalova R; Dvorak J; Tlaskalova-Hogenova H; Cermakova M; Tomasova P; Sediva B; Kuzma M; Bulant J; Bilej M; Hrabak P; Meisnerova E; Lambertova A; Papezova H
Microorganisms; 2019 Sep; 7(9):. PubMed ID: 31510101
[TBL] [Abstract][Full Text] [Related]
12. Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome.
Zhuang X; Tian Z; Luo M; Xiong L
BMC Gastroenterol; 2020 Jun; 20(1):187. PubMed ID: 32532214
[TBL] [Abstract][Full Text] [Related]
13. Spatial heterogeneity of bacterial colonization across different gut segments following inter-species microbiota transplantation.
Li N; Zuo B; Huang S; Zeng B; Han D; Li T; Liu T; Wu Z; Wei H; Zhao J; Wang J
Microbiome; 2020 Nov; 8(1):161. PubMed ID: 33208178
[TBL] [Abstract][Full Text] [Related]
14. Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients.
Allegretti JR; Kassam Z; Mullish BH; Chiang A; Carrellas M; Hurtado J; Marchesi JR; McDonald JAK; Pechlivanis A; Barker GF; Miguéns Blanco J; Garcia-Perez I; Wong WF; Gerardin Y; Silverstein M; Kennedy K; Thompson C
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):855-863.e2. PubMed ID: 31301451
[TBL] [Abstract][Full Text] [Related]
15. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis.
Maslennikov R; Ivashkin V; Efremova I; Poluektova E; Kudryavtseva A; Krasnov G
World J Gastroenterol; 2022 Mar; 28(10):1067-1077. PubMed ID: 35431497
[TBL] [Abstract][Full Text] [Related]
16. Small intestinal bacterial overgrowth in Alzheimer's disease.
Kowalski K; Mulak A
J Neural Transm (Vienna); 2022 Jan; 129(1):75-83. PubMed ID: 34797427
[TBL] [Abstract][Full Text] [Related]
17. Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML.
Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Kazadi D; Halaweish H; Khan MH; Hoeschen A; Cao Q; Luo X; Kabage AJ; Lopez S; Holtan SG; Weisdorf DJ; Khoruts A; Staley C
J Clin Oncol; 2023 Dec; 41(34):5306-5319. PubMed ID: 37235836
[TBL] [Abstract][Full Text] [Related]
18. Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity.
Wilson BC; Vatanen T; Jayasinghe TN; Leong KSW; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Holland DJ; Cutfield WS; O'Sullivan JM
Microbiome; 2021 May; 9(1):107. PubMed ID: 33985595
[TBL] [Abstract][Full Text] [Related]
19. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota.
Huang HL; Chen HT; Luo QL; Xu HM; He J; Li YQ; Zhou YL; Yao F; Nie YQ; Zhou YJ
J Dig Dis; 2019 Aug; 20(8):401-408. PubMed ID: 31070838
[TBL] [Abstract][Full Text] [Related]
20. Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial.
Craven L; Rahman A; Nair Parvathy S; Beaton M; Silverman J; Qumosani K; Hramiak I; Hegele R; Joy T; Meddings J; Urquhart B; Harvie R; McKenzie C; Summers K; Reid G; Burton JP; Silverman M
Am J Gastroenterol; 2020 Jul; 115(7):1055-1065. PubMed ID: 32618656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
